A Meta-Analysis for CXCR4 as a Prognostic Marker and Potential Drug Target in Non-Small Cell Lung Cancer

Drug Design, Development and Therapy - New Zealand
doi 10.2147/dddt.s81564
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Informa UK Limited

Related search

Clinicopathological Significance and Potential Drug Target of RUNX3 in Non-Small Cell Lung Cancer: A meta-Analysis

Drug Design, Development and Therapy
Drug DiscoveryPharmacologyPharmaceutical Science
2015English

CD24+/CD38- As New Prognostic Marker for Non-Small Cell Lung Cancer

Multidisciplinary Respiratory Medicine
PulmonaryRespiratory Medicine
2013English

Minichromosome Maintenance Protein 7 Is a Potential Therapeutic Target in Human Cancer and a Novel Prognostic Marker of Non-Small Cell Lung Cancer

Molecular Cancer
Cancer ResearchOncologyMolecular Medicine
2011English

Hmgb1: A Potential Therapeutic Target for Non-Small Cell Lung Cancer

Lettters in Health & Biological Sciences
2016English

Serum Pleiotrophin as a Diagnostic and Prognostic Marker for Small Cell Lung Cancer

Journal of Cellular and Molecular Medicine
Molecular MedicineCell Biology
2019English

The Value of MicroRNA-155 as a Prognostic Factor for Survival in Non-Small Cell Lung Cancer: A Meta-Analysis

PLoS ONE
Multidisciplinary
2015English

Clinicopathological Significance and a Potential Drug Target of RARβ In Non-Small-Cell Lung Carcinoma: A Meta-Analysis and a Systematic Review

Drug Design, Development and Therapy
Drug DiscoveryPharmacologyPharmaceutical Science
2016English

Prognostic Significance of Immune Cells in Non-Small Cell Lung Cancer: Meta-Analysis

Oncotarget
Oncology
2018English

Drug Resistance in Non-Small Cell Lung Cancer: A Potential for NOTCH Targeting?

Frontiers in Oncology
Cancer ResearchOncology
2018English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy